CME vs VCEL · P/E 22, rev $6.52B vs P/E 835, rev $237.2M
CME Group Inc (CME) versus Vericel Corp Ord (VCEL) — a side-by-side from cached financials, not a winner call.
CME Group Inc (CME) is a financial data & stock exchanges company listed on NASDAQ.
Vericel Corp Ord (VCEL) is a biotechnology company listed on US.
Latest reported CME revenue for 2025-12-31 was $6.52B. Net income was $4.07B. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. CME currently screens at market cap $91.25B and trailing P/E 21.9.
Latest reported VCEL revenue for 2024-12-31 was $237.2M. Net income was $10.4M. Revenue was up 20.1% from 2023-12-31 to 2024-12-31. VCEL currently screens at market cap $2.10B and trailing P/E 834.8.
CME currently screens at market cap $91.25B and trailing P/E 21.9. VCEL currently screens at market cap $2.10B and trailing P/E 834.8.
Not investment advice. Open the CME and VCEL stock pages for the full models.
Not investment advice.